Rare case of COVID-19 vaccine-associated intracranial haemorrhage with venous sinus thrombosis
2021; BMJ; Volume: 14; Issue: 9 Linguagem: Inglês
10.1136/bcr-2021-245092
ISSN1757-790X
AutoresPujon Purkayastha, Charlie Mckechnie, Pallavi Kalkur, Marie Scully,
Tópico(s)Venous Thromboembolism Diagnosis and Management
ResumoVaccine-induced immune thrombotic thrombocytopenia (VITT) is a relatively novel term which describes patients who have developed a low platelet count and prothrombotic tendencies secondary to receiving a vaccine. The concept has been derived from the well-established phenomenon of heparin-induced thrombocytopenia, and several cases of VITT have now been reported in patients who have received the AstraZeneca (ChAdOx1 nCov-19) vaccine. Unfortunately, some of these patients have gone on to develop intracranial venous sinus thrombosis. We present a case of VITT-associated sinus thrombosis secondary to the AstraZeneca (ChAdOx1 nCov-19) vaccine, which was complicated by a large intracerebral haemorrhage.
Referência(s)